Back

Impact of cardiovascular disease burden on the severity of COVID-19 patients

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: ePosters in Cardiovascular disease in special populations (1) Autoimmune/Chronic Inflammatory Disorders and Heart Disease HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Diogo De Almeida Fernandes

Coimbra Hospital and University Center, Coimbra (Portugal)

6 More presentations in this session

Presentation thumbnail
Long-term cardiovascular outcomes after severe burn injury
Ms V. Krbcova Moudra (Prague, CZ)
Abstract Slides Video
Presentation thumbnail
Prognostic impact of 18F-fluorodeoxyglucose positron emission tomography and 67gallium scintigraphy in cardiac sarcoidosis.
Doctor Y. Takigami (Sagamihara, JP)
Abstract Slides Video
Presentation thumbnail
Cancer therapy-related cardiovascular toxicity: what is the accuracy of baseline cardiovascular risk stratification in the prediction of its occurrence?
Doctor N. Cotrim (Santarem, PT)
Abstract Slides Video
Presentation thumbnail
Routine Ankle-Brachial Index (ABI) measurement: a window into atherosclerosis and early left ventricular dysfunction in patients diagnosed with cancer
Doctor M. Slieman (Tel Aviv, IL)
Abstract Slides Video
Presentation thumbnail
Morbidity and mortality of cardio-oncology patients: is there any link to baseline cardiovascular risk?
Doctor B. Andrade (Santarem, PT)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in Cardiovascular disease in special populations (1)

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
The incidence of cardiovascular conditions in patients admitted to hospital with and without COVID-19 in the South-East of Scotland
thumbnail
Congress Presentation
Subgroup analysis of diabetes in COVID-positive revascularized patients: implications for clinical management
thumbnail
Congress Presentation
Determinants of cardiovascular complications post-COVID-19: clinical insights from the LATE-COVID study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources